🇺🇸 FDA
Pipeline program

JADE201

JADE201-01

Phase 1 small_molecule active

Quick answer

JADE201 for Rhematoid Arthritis is a Phase 1 program (small_molecule) at Jade Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Jade Biosciences
Indication
Rhematoid Arthritis
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials